NHS England updates CDF List

NHS England has upded the Cancer Drugs Fund List on its website. We have updated our website to correspond.

NHS England updates CDF List

NHS England has updated the Cancer Drugs Fund List. The latest version (v1.374) was uploaded to the NHS England Website on Tuesday 16, September 2025.

The following changes have been introduced:

Durvalumab (DUR7)

Durvalumab monotherapy for patients with limited- stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiotherapy where the following criteria have been met

Recommended for routine commissioning, receiving CDF interim funding

Enfortumab vedotin in combination with pembrolizumab (ENF1)

Enfortumab vedotin with pembrolizumab for untreated, unresectable or metastatic urothelial cancer, when platinum-based chemotherapy is suitable where the following criteria have been met

Date moving into routine commissioning updated